At the Trump Kennedy Center: Author Shira Boehler (“One Scan Saved My Life”) In Dialogue with Dr. Mehmet Oz and Dr. Kim Lori Sandler on Tuesday, April 14 @6pm

Key Takeaways

• Book release highlights personal impact of early lung‑cancer detection.
• Event features Dr. Mehmet Oz, boosting public health visibility.
• Philips supplies complimentary copies, linking tech brand to screening advocacy.
• Live stream expands audience beyond Washington, D.C. attendees.
• Discussion targets self‑advocacy and policy shifts for CT screening.

Pulse Analysis

Lung cancer remains the leading cause of cancer death in the United States, accounting for roughly 135,000 fatalities annually. Early-stage disease is highly treatable, yet only about 20% of patients are diagnosed before symptoms appear. Low‑dose computed tomography (LDCT) screening, recommended for high‑risk adults, can detect tumors when they are still curable, cutting mortality by up to 20 percent. Despite these gains, screening rates lag due to limited awareness, insurance hurdles, and lingering misconceptions about radiation risk.

Personal narratives like Shira Kupperman Boehler’s are powerful catalysts for change. Her upcoming book, “One Scan Saved My Life,” chronicles how a routine LDCT caught her cancer early, turning a near‑fatal prognosis into a survivorship story. By pairing her testimony with Dr. Mehmet Oz—a household name in health media—and Dr. Kim Lori Sandler, a leading pulmonology researcher, the Kennedy Center event amplifies the message to a broad audience. Philips’ sponsorship, providing free copies of the book, underscores the medical‑technology industry’s vested interest in expanding screening adoption and showcases how corporate partners can support public‑health education.

The event’s timing aligns with ongoing policy debates about Medicare coverage and state‑level screening mandates. High‑visibility forums can pressure regulators to streamline reimbursement and encourage providers to integrate LDCT into routine care pathways. Moreover, the live‑stream format extends the conversation beyond Washington, D.C., reaching patients, caregivers, and clinicians nationwide. As awareness grows, demand for affordable screening solutions is likely to rise, spurring innovation in imaging technology and potentially reshaping the lung‑cancer care market.